AMRX — Amneal Pharmaceuticals, Inc. stock price, charts and financials

QT74Amneal Pharmaceuticals, Inc.

Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
18.48
-0.37-1.96%
OverviewShort InterestFilings
AMRXQT74Amneal Pharmaceuticals, Inc.·NASDAQ
18.48-1.96%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 03, 20268-KCurrent report
Jul 31, 20268-KCurrent report
Jul 30, 20268-KCurrent report
Jul 30, 2026DEFA14AAdditional proxy soliciting materials
Jun 29, 2026DEFM14ADefinitive proxy statement (merger)
Jun 18, 2026PREM14APREM14A
May 12, 20264Statement of changes in beneficial ownership
May 08, 20264Statement of changes in beneficial ownership
May 08, 20264Statement of changes in beneficial ownership
May 08, 20264Statement of changes in beneficial ownership
May 08, 20264Statement of changes in beneficial ownership
May 08, 20264Statement of changes in beneficial ownership
May 08, 20264Statement of changes in beneficial ownership
May 08, 20264Statement of changes in beneficial ownership
May 08, 20264Statement of changes in beneficial ownership
May 07, 202610-QQuarterly report
May 07, 20268-KCurrent report
May 07, 20268-KCurrent report
Apr 27, 2026SC 13GBeneficial ownership statement (passive)
Apr 23, 2026DEFA14AAdditional proxy soliciting materials
Apr 22, 20268-KCurrent report
Apr 22, 2026DEFA14AAdditional proxy soliciting materials
Apr 22, 2026DEFA14AAdditional proxy soliciting materials
Apr 22, 2026DEFA14AAdditional proxy soliciting materials
Apr 22, 2026DEFA14AAdditional proxy soliciting materials
#1 / 25 of 288
Page
▼
/ 12